Obbligazione Dupont de Nemours 3.25% ( US263534BY40 ) in USD

Dupont de Nemours

100 USD ⇌

Stati Uniti

US263534BY40 ( in USD )

3.25% per anno ( pagato 2 volte l'anno)

15/01/2015 - Obbligazione è scaduto

Prospetto opuscolo dell'obbligazione DuPont US263534BY40 in USD 3.25%, scaduta

2 000 USD

1 000 000 000 USD

263534BY4

NR

NR

DuPont de Nemours, Inc. è una società multinazionale statunitense che opera nel settore chimico, producendo una vasta gamma di materiali e prodotti per diversi settori industriali.

The Obbligazione issued by Dupont de Nemours ( United States ) , in USD, with the ISIN code US263534BY40, pays a coupon of 3.25% per year.
The coupons are paid 2 times per year and the Obbligazione maturity is 15/01/2015

The Obbligazione issued by Dupont de Nemours ( United States ) , in USD, with the ISIN code US263534BY40, was rated NR by Moody's credit rating agency.

The Obbligazione issued by Dupont de Nemours ( United States ) , in USD, with the ISIN code US263534BY40, was rated NR by Standard & Poor's ( S&P ) credit rating agency.

e424b2
Page 1 of 60
424B2 1 w76062b2e424b2.htm 424B2
http://www.sec.gov/Archives/edgar/data/30554/000095012309058538/w76062b2e424b2.h... 11/6/2009

e424b2
Page 2 of 60
Table of Contents

Registration No. 333-150613
Filed pursuant to Rule 424(b)(2)

CALCULATION OF REGISTRATION FEE

Title of Each Class

Proposed
Proposed Maximum Amount of
of Securities
Amount to be
Maximum Offering
Aggregate
Registration
to be Registered

Registered
Price Per Share(1)
Offering Price

Fee(2)
Debt Securities
$2,000,000,000
$
$1,993,420,000 $111,232.84

(1) The 3.250% Notes have a maximum offering price of 99.757%. The 4.625% Notes have a
maximum offering price of 99.585%.

(2) Calculated in accordance with Rule 457(r) of the Securities Act of 1933, as amended.

PROSPECTUS SUPPLEMENT (To prospectus dated May 2, 2008)

$2,000,000,000

E. I. du Pont de Nemours and Company

$1,000,000,000 3.250% Notes due January 15, 2015

$1,000,000,000 4.625% Notes due January 15, 2020

We will pay interest on the notes referenced above (the "Notes") on January 15 and
July 15 of each year, beginning July 15, 2010. We may redeem the Notes prior to
maturity, in whole or in part, as described in this prospectus supplement. If we experience
a Change of Control Triggering Event (as defined herein), we may be required to offer to
purchase the Notes from holders. See "Description of Notes -- Change of Control."

Public
Underwriting Proceeds before

Offering Price(1)
Discount

Expenses

Per 3.250% Note

99.757 %
0.35 %
99.407 %
Total
$ 997,570,000
$ 3,500,000 $ 994,070,000

Per 4.625% Note

99.585 %
0.45 %
99.135 %
Total
$ 995,850,000
$ 4,500,000 $ 991,350,000

Combined Total for 3.250% Notes and
4.625% Notes
$ 1,993,420,000 $ 8,000,000 $ 1,985,420,000

(1) Plus accrued interest, if any, from November 9, 2009.

Neither the Securities and Exchange Commission nor any state securities
commission has approved or disapproved of these securities or determined if this
prospectus supplement or either accompanying prospectus is truthful or complete.
Any representation to the contrary is a criminal offense.

The Notes will be ready for delivery in book-entry form only through The Depository
Trust Company on or about November 9, 2009.

http://www.sec.gov/Archives/edgar/data/30554/000095012309058538/w76062b2e424b2.h... 11/6/2009

e424b2
Page 3 of 60
Joint Bookrunners

Credit Suisse
J.P. Morgan
Morgan Stanley
BofA Merrill Lynch Citi Deutsche Bank Securities
Goldman, Sachs & Co. RBS UBS Investment Bank

Co-Managers

Barclays Capital

BBVA Securities

BNP Paribas
HSBC

ING Wholesale

Mitsubishi UFJ Securities
Mizuho Securities USA Inc.
RBC Capital Markets

Santander Investment
Scotia Capital
Standard Chartered Bank
The Williams Capital Group,

L.P.

Wells Fargo Securities

The date of this prospectus supplement is November 4, 2009.
http://www.sec.gov/Archives/edgar/data/30554/000095012309058538/w76062b2e424b2.h... 11/6/2009

e424b2
Page 4 of 60

TABLE OF CONTENTS

PROSPECTUS SUPPLEMENT
ABOUT DUPONT
S-2
RATIO OF EARNINGS TO FIXED CHARGES
S-2
USE OF PROCEEDS
S-3
DESCRIPTION OF NOTES
S-4
UNITED STATES FEDERAL TAXATION
S-10
UNDERWRITING
S-11
NOTICE TO CANADIAN RESIDENTS
S-14
LEGAL OPINIONS
S-15
EXPERTS
S-15
PROSPECTUS
ABOUT THIS PROSPECTUS

1
WHERE YOU CAN FIND MORE INFORMATION

1
FORWARD-LOOKING INFORMATION

3
ABOUT DUPONT

3
RISK FACTORS

4
USE OF PROCEEDS

5
RATIO OF EARNINGS TO FIXED CHARGES

6
DESCRIPTION OF DEBT SECURITIES

6
UNITED STATES FEDERAL TAXATION

13
PLAN OF DISTRIBUTION

16
LEGAL OPINION

17
EXPERTS

17

You should rely only on the information contained in this prospectus supplement and the
accompanying prospectus. We have not authorized anyone to provide you with information different
from that contained in this prospectus supplement and the accompanying prospectus. We are offering
to sell Notes and making offers to buy Notes only in jurisdictions in which offers and sales of the
Notes are permitted. The information contained in this prospectus supplement and the accompanying
prospectus is accurate only as of the date of this prospectus supplement, regardless of the time of
delivery of this prospectus supplement and the accompanying prospectus or any sale of the Notes. In
this prospectus supplement and the accompanying prospectus, the "Company," "we," "us" and "our"
refer to E. I. du Pont de Nemours and Company.

If we use a capitalized term in this prospectus supplement and do not define the term, it is defined
in the accompanying prospectus.

The Notes are offered globally for sale only in those jurisdictions in the United States, Canada,
Europe, Asia and elsewhere in which it is lawful to make such offers. See "Underwriting."

The distribution of this prospectus supplement and the accompanying prospectus and the offering
of the Notes in certain jurisdictions may be restricted by law. Persons into whose possession this
prospectus supplement and the accompanying prospectus come should inform themselves about and
observe any such restrictions. This prospectus supplement and the accompanying prospectus do not
constitute, and may not be used in connection with, an offer or solicitation by anyone in any
jurisdiction in which such offer or solicitation is not authorized or in which the person making such
offer or solicitation is not qualified to do so or to any person to whom it is unlawful to make such offer
or solicitation. See "Underwriting."

References herein to "$" and "dollars" are to the currency of the United States.

S-1
http://www.sec.gov/Archives/edgar/data/30554/000095012309058538/w76062b2e424b2.h... 11/6/2009

e424b2
Page 5 of 60
http://www.sec.gov/Archives/edgar/data/30554/000095012309058538/w76062b2e424b2.h... 11/6/2009

e424b2
Page 6 of 60
Table of Contents

ABOUT DUPONT

We were founded in 1802 and incorporated in Delaware in 1915. We have been in continuous
operation for over 200 years. Our principal offices are at 1007 Market Street in Wilmington,
Delaware.

We are a world leader in science and technology in a range of disciplines including biotechnology,
electronics, materials science, safety and security, and synthetic fibers. We operate globally,
manufacturing a wide range of products for distribution and sale to many different markets, including
the transportation, safety and protection, construction, motor vehicle, agriculture, home furnishings,
medical, electronics, communications, protective apparel, and the nutrition and health markets.

Effective October 1, 2009, we consolidated our 23 businesses into 13 businesses, each with clear
accountability for profit-and-loss and cash management and a direct reporting line to our senior
leadership team. We also re-defined our external financial reporting from the five existing segments to
the following seven segments, which aggregate our 13 businesses:

· Agriculture & Nutrition (Pioneer Hi-Bred, Crop Protection, Nutrition & Health);

·

Electronics
& Communications;

·

Performance
Coatings;

· Performance Materials (Performance Polymers and Packaging & Industrial Polymers);

· Safety & Protection (Protection Technologies, Building Innovations, Safety Resources);

· Performance Chemicals (Chemicals and Fluoroproducts, Titanium Technologies); and

·

Pharmaceuticals.

We intend to report our financial statements for the year ended December 31, 2009, including the
first period in which the re-segmentation became effective (the fourth quarter of 2009), on the basis of
this new segmentation in our Annual Report on Form 10-K for such year, which will be automatically
incorporated by reference into this prospectus supplement upon filing with the SEC. Consistent with
Disclosures about Segments of an Enterprise and Related Information, we also intend to restate our
financial statements for the two years ended December 31, 2008 on the basis of this new segmentation
in such Annual Report. Our Quarterly Report on Form 10-Q for the period ended September 30, 2009,
which is incorporated by reference into this prospectus supplement, reflects our five-segment reporting
structure that was in place through the end of such period.

RATIO OF EARNINGS TO FIXED CHARGES

The following table sets forth our ratio of earnings to fixed charges for each of the periods
indicated:

Nine Months Ended

Years Ended December 31,

September 30, 2009
2008 2007 2006 2005 2004

Ratio of Earnings to Fixed Charges

4.6 x
5.5 x 7.8 x 6.6 x 6.7 x 5.0x

For purposes of calculating the ratio of earnings to fixed charges, (i) "earnings" represent the sum
of income before cumulative effect of changes in accounting principles, provision for (benefit from)
income taxes, minority interests in earnings (losses) of consolidated subsidiaries, adjustment for
companies accounted for by the equity method, capitalized interest and amortization of capitalized
interest plus fixed charges, and (ii) "fixed charges" represent the sum of interest and debt expense,
capitalized interest and rental expense representative of interest factor. The ratio is based solely on
historical financial information.

S-2
http://www.sec.gov/Archives/edgar/data/30554/000095012309058538/w76062b2e424b2.h... 11/6/2009

e424b2
Page 7 of 60
http://www.sec.gov/Archives/edgar/data/30554/000095012309058538/w76062b2e424b2.h... 11/6/2009

e424b2
Page 8 of 60
Table of Contents

USE OF PROCEEDS

We will use the net proceeds from the sale of the Notes, which are expected to be approximately
$1,984,670,000 after payment of expenses related to the offering, for general corporate purposes.
These purposes may include repayment and refinancing of debt, acquisitions, working capital, capital
expenditures and repurchases and redemptions of securities (including, subject to market conditions,
the possible redemption of our outstanding $900 million aggregate principal amount 41/8% Notes due
April 30, 2010). Pending any specific application, we may initially invest funds in cash equivalents
and short-term marketable securities or apply them to the reduction of short-term indebtedness.

S-3
http://www.sec.gov/Archives/edgar/data/30554/000095012309058538/w76062b2e424b2.h... 11/6/2009

e424b2
Page 9 of 60
Table of Contents

DESCRIPTION OF NOTES

The following description of the particular terms of the 3.250% Notes due January 15, 2015 (the
``3.250% Notes") and the 4.625% Notes due January 15, 2020 (the ``4.625% Notes") offered hereby
(referred to in the prospectus as the "Debt Securities") supplements the description of the general
terms and provisions of the Debt Securities included in the accompanying prospectus. The
3.250% Notes and the 4.625% Notes are collectively referred to in this prospectus supplement as the
"Notes." The following summary of the Notes is qualified in its entirety by reference in the
accompanying prospectus to the description of the Indenture dated as of June 1, 1992 (the
"Indenture"), between the Company and Deutsche Bank Trust Company Americas, formerly known as
Bankers Trust Company, as trustee (the "Trustee").

General

The 3.250% Notes will mature at par on January 15, 2015. The 4.625% Notes will mature at par
on January 15, 2020. The Notes will constitute part of the senior debt of the Company and will rank
pari passu with all other unsecured and unsubordinated indebtedness of the Company. The Notes will
be issued in fully registered form only, in denominations of $2,000 and additional multiples of $1,000.
Principal of and interest on the Notes will be payable, and the transfer of Notes will be registerable,
through DTC, as described below.

Each 3.250% Note will bear interest from November 9, 2009 at the annual rate of 3.250%. Each
4.625% Note will bear interest from November 9, 2009 at the annual rate of 4.625%. Interest on the
3.250% Notes and the 4.625% Notes will be payable semiannually on January 15 and July 15,
commencing July 15, 2010, to the person in whose name such Note is registered at the close of
business on the 14th calendar day immediately preceding such date (whether or not a Business Day).

Interest payable at the maturity of the Notes will be payable to registered holders of the Notes to
whom principal is payable. Interest will be computed on the basis of a 360-day year of twelve 30-day
months.

If any interest payment date falls on a day that is not a Business Day, the interest payment will be
postponed to the next day that is a Business Day, and no interest on such payment will accrue for the
period from and after such interest payment date. If the maturity date of the Notes falls on a day that is
not a Business Day, the payment of interest and principal may be made on the next succeeding
Business Day, and no interest on such payment will accrue for the period from and after the maturity
date.

Interest payments for the Notes will include accrued interest from and including the date of issue
or from and including the last date in respect of which interest has been paid, as the case may be, to
but excluding the interest payment date or the date of maturity, as the case may be.

The Company may, without the consent of the holders of either series of Notes, issue additional
notes having the same ranking and the same interest rate, maturity and other terms as the Notes of
such series. Any additional notes having such similar terms, together with the Notes of such series,
will constitute a single series of notes under the Indenture. No additional Notes of a series may be
issued if an Event of Default has occurred with respect to the Notes of such series.

As used in this prospectus supplement, "Business Day" means any day, other than a Saturday or
Sunday, that is not a day on which banking institutions are authorized or required by law or regulation
to close in the City of New York.

Book-Entry, Delivery and Form

The Notes will be issued in the form of one or more fully registered global notes (the "Global
Notes") registered in the name of The Depository Trust Company, New York, New York ("DTC") or
Cede & Co., DTC's nominee. Beneficial interests in the Global Notes will be represented through
book-entry accounts of financial institutions acting on behalf of beneficial owners as direct and
indirect participants in DTC and investors will hold such beneficial interests only through DTC, or
through Clearstream Banking, S.A. or Euroclear Bank S.A./N.V. as DTC participants. Beneficial
http://www.sec.gov/Archives/edgar/data/30554/000095012309058538/w76062b2e424b2.h... 11/6/2009

e424b2
Page 10 of 60
interests in the Global Notes will be held in denominations of $2,000 and additional multiples of
$1,000. Except as described below, the Global Notes may

S-4
http://www.sec.gov/Archives/edgar/data/30554/000095012309058538/w76062b2e424b2.h... 11/6/2009